Factors impacting progression-free survival (PFS) as a predictor of overall survival (OS)

被引：1
|
作者：
Stewart, David J.
Bosse, Dominick
Hilton, John Frederick
Goss, Glenwood D.
Fung-Kee-Fung, Michael
Jonker, Derek J.
机构：
[1] Ottawa Hosp, Ottawa, ON, Canada
[2] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada
[3] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[4] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.6556
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6556
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Progression-free survival (PFS) and overall survival (OS) in patients receiving three targeted therapies (TTs) for metastatic renal cell carcinoma (mRCC)
    Verzoni, Elena
    Iacovelli, Roberto
    Rizzo, Mimma
    Felici, Alessandra
    Cascinu, Stefano
    Di Lorenzo, Giuseppe
    Cerbone, Linda
    Ortega, Cinzia
    Masini, Cristina
    Giganti, Maria Olga
    Lorusso, Vito
    Messina, Caterina
    Atzori, Francesco
    De Vincenzo, Fabio
    Sacco, Cosimo
    Boccardo, Francesco
    Valduga, Francesco
    Massari, Francesco
    Tassi, Renato
    Procopio, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [22] Evaluating the relationship between progression-free survival (PFS) and overall survival (OS) in clinical trials of patients (pts) with metastatic colorectal cancer (mCRC)
    Sidhu, R.
    Rong, A.
    Dahlberg, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [23] EFFECT OF REDUCTION OF CIRCULATING TUMOR CELLS (CTCS) ON PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN METASTATIC BREAST CANCER (MBC) PATIENTS
    Giuliano, M.
    Giordano, A.
    Handy, B. C.
    Ueno, N.
    Andreopoulou, E.
    Alvarez, R. H.
    Valero, V.
    Hortobagyi, G. N.
    Reuben, J.
    Cristofanilli, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 32 - 33
  • [24] Exploring the relation between overall survival (OS) and progression-free survival (PFS) in gastrointestinal stromal tumor (GIST) via meta-analysis.
    Keyser, R. L.
    Freier, K. E. Tranbarger
    Hoaglin, D. C.
    Tzivelekis, S.
    Ozer-Stillman, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] DRUG COST PER GAINED MONTH IN OVERALL SURVIVAL (OS) AND PROGRESSION-FREE SURVIVAL (PFS) OF SELECTED SOLID TUMOUR THERAPIES IN NORDIC COUNTRIES
    Osterlund, P.
    Pfeiffer, P.
    Smaaland, R.
    Rodrigues, F.
    Furneri, G.
    ANNALS OF ONCOLOGY, 2014, 25
  • [26] Association of progression-free survival (PFS) with overall survival (OS) in advanced biliary tract cancer (BTC): A trialand patient-level analysis
    Castet, F.
    Fabregat-Franco, C.
    Kim, J. W.
    Rimini, M.
    Lacasta, A.
    Kang, M.
    Salani, F.
    Castillo Trujillo, A. O.
    Lopez Valbuena, D. E.
    Basagana-Farres, M.
    Adeva, J. A.
    Munoz Martin, A. J.
    Hyung, J.
    Rimassa, L.
    Casadei Gardini, A.
    Yoo, C.
    Macarulla Mercade, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S121 - S121
  • [27] Prognostic Factors for Progression-free Survival and Overall Survival Αfter Recurrence of Glioblastoma
    Zemskova, Oksana
    Yu, Nathan y.
    Leppert, Jan
    Rades, Dirk
    ANTICANCER RESEARCH, 2024, 44 (07) : 3059 - 3066
  • [28] Progression-free survival (PFS) in oncology: caveat emptor!
    Sarac, Sinan B.
    Ainsworth, Mark A.
    Hovgaard, Doris
    Bjerrum, Ole W.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 124 (03) : 237 - 238
  • [29] FIRST-TO-SECOND PROGRESSION-FREE SURVIVAL RATIO AS A PREDICTOR FOR OVERALL SURVIVAL IN OVARIAN CANCER
    Salman, L.
    Gandelsman, E.
    Romano, A.
    Sabah, G.
    Jakobson-Setton, A.
    Borovich, A.
    Yeoshoua, E.
    Eitan, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A135 - A136
  • [30] Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer
    Halabi, Susan
    Vogelzang, Nicholas J.
    Ou, San-San
    Owzar, Kouros
    Archer, Laura
    Small, Eric J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (17) : 2766 - 2771
12345